397 related articles for article (PubMed ID: 27984637)
1. Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.
Tasian SK; Hunger SP
Br J Haematol; 2017 Mar; 176(6):867-882. PubMed ID: 27984637
[TBL] [Abstract][Full Text] [Related]
2. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
Tasian SK; Loh ML; Hunger SP
Cancer; 2015 Oct; 121(20):3577-90. PubMed ID: 26194091
[TBL] [Abstract][Full Text] [Related]
3. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
Tran TH; Hunger SP
Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Sequencing in Acute Lymphoblastic Leukemia.
Coccaro N; Anelli L; Zagaria A; Specchia G; Albano F
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208040
[TBL] [Abstract][Full Text] [Related]
5. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia.
Pui CH; Nichols KE; Yang JJ
Nat Rev Clin Oncol; 2019 Apr; 16(4):227-240. PubMed ID: 30546053
[TBL] [Abstract][Full Text] [Related]
6. Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia.
Irving JA
Br J Haematol; 2016 Mar; 172(5):655-66. PubMed ID: 26568036
[TBL] [Abstract][Full Text] [Related]
7. Insights of Acute Lymphoblastic Leukemia with Development of Genomic Investigation.
Xu H; Shu Y
Methods Mol Biol; 2018; 1754():387-413. PubMed ID: 29536454
[TBL] [Abstract][Full Text] [Related]
8. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia.
Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH
Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251
[No Abstract] [Full Text] [Related]
9. The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions.
Bhatla T; Jones CL; Meyer JA; Vitanza NA; Raetz EA; Carroll WL
J Pediatr Hematol Oncol; 2014 Aug; 36(6):413-8. PubMed ID: 24942023
[TBL] [Abstract][Full Text] [Related]
10. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?
Izraeli S
Br J Haematol; 2010 Oct; 151(2):119-31. PubMed ID: 20678159
[TBL] [Abstract][Full Text] [Related]
11. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung C; Ma H
Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
[TBL] [Abstract][Full Text] [Related]
12. Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.
Bleckmann K; Schrappe M
Br J Haematol; 2016 Mar; 172(6):855-69. PubMed ID: 26773444
[TBL] [Abstract][Full Text] [Related]
13. Treatment and biology of pediatric acute lymphoblastic leukemia.
Kato M; Manabe A
Pediatr Int; 2018 Jan; 60(1):4-12. PubMed ID: 29143423
[TBL] [Abstract][Full Text] [Related]
14. [Childhood acute lymphoblastic leukemia; pathophysiology and treatment strategy].
Tsurusawa M
Rinsho Ketsueki; 2013 Nov; 54(11):2038-46. PubMed ID: 24305536
[No Abstract] [Full Text] [Related]
15. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
Mullighan CG
Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
[TBL] [Abstract][Full Text] [Related]
16. [Present status of individualized therapy in childhood acute lymphoblastic leukemia].
Wang J; Chen C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1617-22. PubMed ID: 24370059
[TBL] [Abstract][Full Text] [Related]
17. Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients.
Page EC; Heatley SL; Yeung DT; Thomas PQ; White DL
Cancer Lett; 2018 Sep; 432():69-74. PubMed ID: 29879498
[TBL] [Abstract][Full Text] [Related]
18. Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.
Wolach O; Amitai I; DeAngelo DJ
Br J Haematol; 2017 Dec; 179(5):705-723. PubMed ID: 29076138
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.
Heikamp EB; Pui CH
J Pediatr; 2018 Dec; 203():14-24.e2. PubMed ID: 30213460
[No Abstract] [Full Text] [Related]
20. Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.
Jackson RK; Irving JA; Veal GJ
Br J Haematol; 2016 Apr; 173(1):13-24. PubMed ID: 26729065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]